MADISON, Wis. ( Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent
Sometimes stocks making big moves have been hit with an
>>5 Breakout Stocks Ready to Surge Higher
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
With that in mind, let's take a closer look at a
several stocks under $10 that are making large moves to the upside today.
>>5 Stocks Under $10 Set to Soar
) is a clinical-stage pharmaceutical company that develops therapeutic candidates for the treatment of cancer and inflammation. This stock is trading up 6.7% to $1.91 in recent trading.
Today's Range: $1.74-$1.94
52-Week Range: $1.23-$3.73
Three-Month Average Volume: 59,505
>>3 Hot Stocks to Trade (or Not)
From a technical perspective, ENMD is ripping higher here right above some near-term support at $1.63 with above-average volume. This move is quickly pushing shares of ENMD within range of triggering a major breakout trade. That trade will hit if ENMD manages to take out its 50-day moving average at $1.95 with high volume.
Traders should now look for long-biased trades in ENMD as long as it's trending above today's low of $1.74 and then once it sustains a move or close above $1.95 with volume that hits near or above 59,505 shares. If that breakout triggers soon, then ENMD will set up to re-test or possibly take out its next major overhead resistance level at $2.40.
) is a biotechnology company engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. This stock is trading up 7.4% to $1.52 in recent trading.